GLP-1 maintenance dose: the four things people mean
Half the maintenance-dose arguments online are two people using the same phrase for different patterns. Here is the ladder, rung by rung, with an honest evidence tier on each.
MaintenanceApplies to Ozempic, Wegovy, Zepbound, Mounjaro and compounded GLP-1sUpdated August 2026
Why maintenance dosing became a movement
Three pressures created it. Cost: at $500 to $1,300 a month self-pay, a dose pattern that halves consumption halves a rent-sized bill. Side effects: what was tolerable during active loss can feel like a bad trade for defending a number. And the forever question: for many people a smaller dose reads as a livable long-term arrangement in a way the full ladder does not. The result is the fastest-growing corner of the GLP-1 community, subs devoted to maintenance and microdosing, running a giant uncontrolled experiment and arguing about the results.
None of that noise resolves anything until you notice that "maintenance dose" means four different patterns, with wildly different evidence behind them. Tap each rung:
Full dose, continued. The label-supported path: you reach goal and simply continue the dose that got you there.
This is the only rung with randomized-trial support. In STEP-4, people who continued semaglutide after twenty weeks kept losing (about 8% further), while those switched to placebo regained most of what they had lost. The trade is cost, supply, and side effects carried indefinitely. It is also the rung the "forever medication" position is really describing.
Descriptive, not prescriptive: what each pattern is and what is known about it. Dosing decisions belong with your prescriber.
What the trials actually established
The clean finding is at the top of the ladder. In STEP-4, everyone took semaglutide for 20 weeks; then half continued and half switched to placebo. The continuers kept losing, roughly another 8%, while the placebo group regained most of their loss. That is strong evidence that ongoing signal maintains the result, and it is the entire trial-grade case for maintenance dosing of any kind. What the trials never tested is the question the community actually cares about: how little signal is enough. Every rung below full dose is that question being answered in public, one person at a time.
A fair way to hold it: the top rung is medicine, the middle rungs are practice running ahead of research, and the bottom rung is a live argument. People succeed and struggle on every rung. What separates the ones who succeed is rarely the dose; it is that they watch a trend, keep a protein floor, and treat the pattern as an experiment with data instead of an identity.
The prescriber conversation
Whatever rung you are considering, the conversation goes better arriving with structure:
Which pattern you mean, in plain words (lower rung, wider interval, or fractional dose).
Why: cost, side effects, supply, or wanting the least medication that holds the line.
What you will watch: the weekly trend and food noise, with your line number stated.
The reconsider trigger: the number or symptom at which you both revisit the plan.
Every rung of the ladder still leaves the same jobs on your desk: protein at roughly 1.6g per kg of goal weight (the calculator gives your number), two to three short strength sessions to keep the furnace, and a watched weekly trend so drift is caught at 3 lbs instead of 15. A maintenance dose lowers the volume on appetite. The structure is what decides whether the result survives contact with real life.
Frequently asked questions
What is a GLP-1 maintenance dose?
It depends on who is talking, which is why the arguments never resolve. People use the phrase for four different patterns: continuing the full treatment dose after goal weight, stepping down to a lower approved dose and holding, keeping the dose but stretching the interval between injections, or true microdosing below the lowest approved rung. Evidence strength falls sharply as you move down that list, so the first step in any maintenance conversation is agreeing which rung you mean.
Is there an official maintenance dose for Ozempic or Wegovy after weight loss?
No. The labels describe treatment dosing, not a post-goal maintenance protocol. Continuing the reached dose is the pattern the trials support: in STEP-4, people who continued semaglutide after 20 weeks kept losing while the placebo-switch group regained. Everything below full dose is practice and community experience running ahead of the research, which does not make it wrong, but does make the evidence tier worth knowing.
Can you stay on a low dose of Ozempic just to maintain?
Many people do, and prescribers increasingly write it, on the reasoning that defending a weight may need less signal than losing to it did. Direct trial evidence for low-dose maintenance is thin. Practically, people who step down watch two things: whether food noise stays quiet at the lower rung, and whether the weekly weight trend holds. If both hold for a few months, the rung is doing its job for them.
What about taking a dose every 10 to 14 days instead of weekly?
This is the most common pattern in the maintenance communities, usually born from cost or supply pressure rather than theory. No trial has tested extended intervals. Pharmacologically it means spending the end of each window at lower drug levels, so returning appetite in the last few days is the signal people navigate by. It is exactly the kind of pattern to be explicit about with your prescriber rather than improvising silently.
Is microdosing a GLP-1 legitimate?
It is the most contested rung. There are no published trials, clinicians disagree in public, and it generally requires compounded product since pens do not fractionate cleanly. People report meaningful appetite control at a fraction of the cost; skeptics note the lowest approved doses were designed as sub-therapeutic titration steps. Both can be true. If you are exploring it, our microdosing chart lays out the reported tiers descriptively, and it is a conversation to have with a prescriber, not a comment section.
How do I know if my maintenance dose is working?
Two signals, watched over weeks rather than days: the weekly weight trend against the line you set, and the loudness of food noise. A maintenance pattern is working when the trend holds and eating is not a fight. If the trend drifts up or the noise returns, that is data for the next prescriber conversation, not a personal failing, and catching it at 3 lbs preserves far more options than noticing at 15.
Sources
STEP-4: Rubino D et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance. JAMA, 2021.
STEP-1 extension: Wilding JPH et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide. Diabetes Obes Metab, 2022.
Community-reported maintenance patterns compiled from r/GLP1microdosing, r/MounjaroMaintenance, and r/Zepbound_Maintenance (2026): extended-interval and submaximal dosing are the dominant reported patterns.
Linked citations open on PubMed or DailyMed, both run by the US National Institutes of Health. Where a claim on this page comes from reporting or clinical commentary we could not resolve to a stable public record, it is listed above without a link rather than pointed at an approximation.